Literature DB >> 21509211

Indicators of Renal Glomerular and Tubular Functions in Patients with Beta-Thalassaemia Major: A cross sectional study at the Royal Hospital, Oman.

Waad-Allah S Mula-Abed1, Huda S Al-Hashmi, Muhanna N Al-Muslahi.   

Abstract

OBJECTIVES: There are limited data concerning the assessment of renal function in beta-thalassaemia major, with no study of such involvement in Omani patients. The objective of this study was to establish the pattern of renal glomerular and tubular function using traditional and specific laboratory tests in patients with beta-thalassaemia major.
METHODS: This cross-sectional study, from January-July 2008, included 30 patients of the Thalassaemia Clinic at the Royal Hospital, Oman, with transfusion-dependent homozygous beta-thalassaemia major. They included 15 males and 15 females, aged 16-32 years with mean ± standard deviation of 21.23 ± 3.42 years. The medical records were reviewed and renal function states assessed as follows: serum creatinine, estimated glomerular filtration rate (eGFR); urea; phosphate, fractional excretion of filtered sodium (FENa); urine albumin: creatinine index; urine ß2-microglobulin:creatinine index; tubular reabsorption of phosphate (TRP), and tubular maximum phosphate reabsorption (TmP)/GFR.
RESULTS: All patients had eGFR >90 ml/min/1.73m(2); serum creatinine <90 μmol/L; serum urea <6.0 mmol/L, and urine albumin:creatinine <2.5 mg/mmol. Only 2 (6.7%) patients had FENa >1% and 3 (10.0%) patients had urine ß2-microglobulin: creatinine >22 μg/mmol. All patients had TRP >0.85, of whom seven (23.3%) patients had values within the range of 0.85-0.95 and 23 (76.7%) had values >0.95. Also, all patients had TmP/GFR >1.0 mmol/L, of whom only one (3.3%) patient had TmP/GFR of 1.0-1.5, and 29 (96.7%) patients had TmP/GFR >1.5 mmol/L. Finally, 24 (80%) patients had serum phosphate >1.4 mmol/L. Linear regression revealed a highly significant correlation between serum phosphate and TmP/GFR (r = 0.904, P < 0.001).
CONCLUSION: Renal function, glomerular and tubular, appears to be well preserved in beta-thalassaemia major. Almost all renal function indicators were within the recommended ranges. Raised TmP/GFR and TRP were noted in the majority of patients, reflecting an up-trend in serum phosphate and therefore increasing renal phosphate reabsorption.

Entities:  

Keywords:  Beta-thalassaemia; Glomerular; Oman; Renal function; Tubular

Year:  2011        PMID: 21509211      PMCID: PMC3074678     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN: 2075-051X


  30 in total

Review 1.  Beta-thalassaemia.

Authors:  S L Thein
Journal:  Baillieres Clin Haematol       Date:  1998-03

2.  Study of hemoglobinopathies in Oman through a national register.

Authors:  A G Rajab; M A Patton; B Modell
Journal:  Saudi Med J       Date:  2000-12       Impact factor: 1.484

3.  Renal function in adult beta-thalassemia/Hb E disease.

Authors:  L Ong-ajyooth; P Malasit; S Ong-ajyooth; S Fucharoen; P Pootrakul; S Vasuvattakul; N Siritanaratkul; S Nilwarangkur
Journal:  Nephron       Date:  1998       Impact factor: 2.847

4.  Prevalence of endocrinopathies in patients with Beta-thalassaemia major - a cross-sectional study in oman.

Authors:  Waad-Allah Mula-Abed; Huda Al Hashmi; Muhanna Al Muslahi; Hilal Al Muslahi; Mohammad Al Lamki
Journal:  Oman Med J       Date:  2008-10

5.  Bone metabolism and mineral density in patients with beta-thalassemia major.

Authors:  Umit Dundar; Alphan Kupesiz; Sebahat Ozdem; Erdal Gilgil; Tiraje Tuncer; Akif Yesilipek; Meral Gultekin
Journal:  Saudi Med J       Date:  2007-09       Impact factor: 1.484

6.  Survival in medically treated patients with homozygous beta-thalassemia.

Authors:  N F Olivieri; D G Nathan; J H MacMillan; A S Wayne; P P Liu; A McGee; M Martin; G Koren; A R Cohen
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

7.  Renal tubular function in beta-thalassemia.

Authors:  A Sumboonnanonda; P Malasit; V S Tanphaichitr; S Ong-ajyooth; S Sunthornchart; S Pattanakitsakul; S Petrarat; A Assateerawatt; A Vongjirad
Journal:  Pediatr Nephrol       Date:  1998-05       Impact factor: 3.714

Review 8.  Pathogenesis and management of osteoporosis in thalassemia.

Authors:  Ersi Voskaridou; Evangelos Terpos
Journal:  Pediatr Endocrinol Rev       Date:  2008-10

Review 9.  Pathophysiology of iron toxicity.

Authors:  R S Britton; G A Ramm; J Olynyk; R Singh; R O'Neill; B R Bacon
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

10.  Tubulopathy in nephrolithiasis: consequence rather than cause.

Authors:  P Jaeger; L Portmann; J M Ginalski; A F Jacquet; E Temler; P Burckhardt
Journal:  Kidney Int       Date:  1986-02       Impact factor: 10.612

View more
  3 in total

1.  Side effects of Deferasirox Iron Chelation in Patients with Beta Thalassemia Major or Intermedia.

Authors:  Murtadha Al-Khabori; Sunil Bhandari; Mohammed Al-Huneini; Khalil Al-Farsi; Vinodh Panjwani; Shahina Daar
Journal:  Oman Med J       Date:  2013-03

2.  Glomerular and Tubular Functions in Children and Adults with Transfusion-Dependent Thalassemia.

Authors:  Agageldi Annayev; Zeynep Karakaş; Serap Karaman; Altan Yalçıner; Alev Yılmaz; Sevinç Emre
Journal:  Turk J Haematol       Date:  2017-07-28       Impact factor: 1.831

3.  Under-recognized Hypoparathyroidism in Thalassemia

Authors:  Hataitip Tangngam; Pat Mahachoklertwattana; Preamrudee Poomthavorn; Ampaiwan Chuansumrit; Nongnuch Sirachainan; La-or Chailurkit; Patcharin Khlairit
Journal:  J Clin Res Pediatr Endocrinol       Date:  2018-05-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.